Showing results (911-920 of 1,032) with videos related to
Sort By:
Pageof 104
Leukemia|April 9, 2010
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group studyP A Ho, T A Alonzo, K J Kopecky, et al.Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.Blood|August 30, 2011
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOGPhoenix A Ho, Kenneth J Kopecky, Todd A Alonzo, et al.Immunity|July 28, 2021
Resident cardiac macrophages mediate adaptive myocardial remodelingNicole R Wong, Jay Mohan, Benjamin J Kopecky, et al.ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12CYoungsook Shin, Joon Won Jeong, Ryan P Wurz, et al.Cancer Immunology, Immunotherapy : CII|June 4, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinationsLorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, et al.Oncogene|June 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancerGeorge Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, et al.Scientific Reports|March 15, 2025
Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumabLorena Incorvaia, Sarah Scagliarini, Fernando Sabino Marques Monteiro, et al.European Urology Open Science|November 24, 2025
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV CohortOndrej Fiala, Francesco Grillone, Kazutoshi Fujita, et al.Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.Pageof 104